Long-Term Effects Of An Early Individualised Retraining Programme On Walking Ability In Patients Following Hemiplegic Stroke (letswalk)

This project aims to study the effects early individualised retraining programme on walking ability in patients following hemiplegic stroke.

Study Overview

• Status: Terminated
• Conditions: Stroke

• Study Type: Observational
• Enrollment (Actual): 14

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 85 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Probability Sample

Study Population

patients hospitalized in the Physical Medicine and Rehabilitation (PMR) units of Dijon and Besançon CHU, and the Functional Rehabilitation Centres of Divio (Dijon) and Bregille (Besançon)

Description

Inclusion Criteria:

• Patients benefiting from classical rehabilitation following cardiovascular accident (cerebral infarction or spontaneous intracerebral hematoma) according to current recommendations (conference de consensus sur l'orientation des patients atteints d'AVC des societes Françaises de Medecine Physique et Readaptation (MPR), d'Urgence Neuro-Vasculaire et de Geriatrie et Gerontologie), hospitalized in the Physical Medicine and Rehabilitation (PMR) units of Dijon and Besançon CHU, and the Functional Rehabilitation Centres of Divio (Dijon) and Bregille (Besançon)
• Age between 18 and 85 years.
• Etiological examination carried out according to current recommendations (CT scan and/or MRI, Holter ECG and Holter blood pressure, Doppler of the supra-aortic trunks, echocardiography).
• Patients referred to the PMR unit less than one month after the cerebral vascular accident.
• Clinical status considered stable from a cardiovascular and neurological point of view with a well-balanced medical treatment (anti-hypertensives, anti-coagulants or antiplatelets, oral antidiabetics if necessary)
• Patients able to understand the instructions and the interest of retraining.
• Patients who have provided written informed consent for the study.

Exclusion Criteria:

• Existence of disorders associated with hemiplegic motor impairment: disorders of memory and superior functions (MMSE < 24) and impaired ability to understand (BDAE <3), deep sensitivity disorders, severe unilateral neglect (bells test).
• Patients referred following meningeal hemorrhage or deep vein thrombosis
• Recurrent stroke, whatever the severity of the sequelae of the previous stroke.
• Existence of cerebellar involvement as a major aspect of the clinical picture
• Myocardial infarction or heart surgery within the preceding 6 months.
• Severe heart failure (NYHA >3 or left ventricular ejection fraction (LVEF) <40%).
• Subjects presenting with complete non-stabilized arrhythmia
• Any metabolic, infectious, inflammatory, respiratory or cardiovascular disease that is not stabilized or constitutes a contra indication to retraining (chronic respiratory insufficiency (obstructive or restrictive), severe valve disease, obstructive heart disease, severe progressive heart rhythm or conduction disorders, intracavitary thrombus.
• Symptomatic peripheralartery disease (Leriche and Fontaine stage 3 or 4).
• Any other debilitating neurological disease (multiple sclerosis, Parkinson's disease).
• Participation in another biomedical research protocol during the retraining period (8 weeks minimum)
• Patients under guardianship or ward of court.

Study Plan

How is the study designed?

Number of groups / cohorts

2

Cohorts and Interventions

Group / Cohort
The control group; will receive support "traditional"10 hours per week: techniques called neuro-facilitators
test group; enjoy the same support as control group at 7 hours week, coupled with a personalized retraining effort ergometer for 3 hours per week: after a 5 minute warm to 50% of Heart Rate Maximum (HRmax) of the initial test effort (TE), continuous work of 20 minutes at an intensity corresponding to 70% HRmax, followed by a recovery period of 5 min between active 40 and 50% of maximum heart rate (5 times per week).

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Neuromotor capacity	The walking speed of 10 meters.; The level of disability by the scale of the Functional Independence Measure (FIM) - Functional walking ability, assessed clinically by Functional Ambulation Classification (FAC), as amended to Month 2 and Month 6.; The ability to balance by static posturography: a collection of the path length not the center of the plantar pressure stabilogram.	participants will be followed for the duration of hospital stay, an expected average of 12 months
functional capacity	The walking speed of 10 meters.; The level of disability by the scale of the Functional Independence Measure (FIM) - Functional walking ability, assessed clinically by Functional Ambulation Classification (FAC), as amended to Month 2 and Month 6.; The ability to balance by static posturography: a collection of the path length not the center of the plantar pressure stabilogram.	participants will be followed for the duration of hospital stay, an expected average of 12 months

Collaborators and Investigators

• Sponsor: Centre Hospitalier Universitaire Dijon

Study record dates

Study Major Dates

• Study Start: May 1, 2010
• Primary Completion (Actual): September 1, 2011
• Study Completion (Actual): September 1, 2011

Study Registration Dates

• First Submitted: July 17, 2013
• First Submitted That Met QC Criteria: July 24, 2013
• First Posted (Estimate): July 25, 2013

Study Record Updates

• Last Update Posted (Estimate): July 25, 2013
• Last Update Submitted That Met QC Criteria: July 24, 2013
• Last Verified: July 1, 2013

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Cardiovascular Diseases; Vascular Diseases; Cerebrovascular Disorders; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Stroke
• Other Study ID Numbers: Casillas PHRC IR 2009